Publications by authors named "Yingming Xue"

Claim this Profile
L
Large left paraduodenal hernia identified and repaired by laparoscopy: A case report.
Yingming Xue, Chao Liu, Bin Lin, Pengcheng Ding, Hong Qi

J Int Med Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of transmembrane protein 41A is associated with metastasis via the modulation of E‑cadherin in radically resected gastric cancer.
Bin Lin, Yingming Xue, Chao Qi, Xiangjie Chen, Weizheng Mao

Mol Med Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DDA1 promotes stage IIB-IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling.
Senlin Zhao, Huamei Tang, Dongwang Yan, Junwei Fan, Hongcheng Sun, Yingming Xue, Xuebin Qin

Oncotarget· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Yu-Peng Wang, Guo-He Song, Jian Chen, Chao Xiao, Chao Li, Ying-Ming Xue

Tumour Biol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of rs5764455 and rs6006473 polymorphisms in PARVB with liver damage of nonalcoholic fatty liver disease in Han Chinese population.
Gang Wu, Kai Wang, Yingming Xue, Guohe Song, Yupeng Wang

Gene· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.
Meng Zhang, Feifei Cui, Su Lu, Huijun Lu, Yingming Xue

J Exp Clin Cancer Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
Senlin Zhao, Tao Jiang, Huamei Tang, Feifei Cui, Chenchen Liu, Yingming Xue

J Gastroenterol Hepatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
Jingtao Wang, Feifei Cui, Xiao Wang, Yingming Xue, Jian Chen

J Exp Clin Cancer Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy.
Jian Chen, Huijun Lu, Dongwang Yan, Feifei Cui, Xiaoliang Wang, Yingming Xue

Oncotarget· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc-α-2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population.
Yingming Xue, Fudong Yu, Dongwang Yan, Feifei Cui, Huamei Tang

Int J Mol Sci· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.
Jian Chen, Huamei Tang, Zehua Wu, Chongzhi Zhou, Tao Jiang, Yingming Xue

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis